Literature DB >> 17627058

HPV infections in adolescents.

Anna-Barbara Moscicki1.   

Abstract

Adolescents who are sexually active have the highest rates of prevalent and incident HPV infection rates with over 50-80% having infections within 2-3 years of initiating intercourse. These high rates reflect sexual behavior and biologic vulnerability. Most infections are transient in nature and cause no cytologic abnormality. However, a small number of adolescents will not clear the infection. Persistence of HPV is strongly linked to the development of high-grade squamous intra-epithelial lesions (HSIL) and invasive cancer. The HSIL detected, however, does not appear to progress rapidly to invasive cancer. Understanding the natural history of HPV in adolescents has shed light into optional treatment strategies which include watchful observation of atypical squamous cells of undetermined significance (ASCUS) and low grade (LSIL). The association between age of first intercourse and invasive cancer cannot be ignored. Consequently, initiating screening at appropriate times in this vulnerable group is essential. In addition, with the advent of the HPV vaccine, vaccination prior to the onset of sexual activity is critical since most infections occur within a short time frame post initiation.

Entities:  

Mesh:

Year:  2007        PMID: 17627058      PMCID: PMC3851097          DOI: 10.1155/2007/136906

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  20 in total

1.  Behavioral Decision Research Intervention Reduces Risky Sexual Behavior.

Authors:  Julie S Downs; Wändi Bruine de Bruin; Baruch Fischhoff; Pamela J Murray
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

2.  Overcoming barriers to HPV vaccination: A randomized clinical trial of a culturally-tailored, media intervention among African American girls.

Authors:  Ralph J DiClemente; Colleen Crittenden Murray; Tracie Graham; Julia Still
Journal:  Hum Vaccin Immunother       Date:  2015-09-17       Impact factor: 3.452

3.  High HIV, HPV, and STI prevalence among young Western Cape, South African women: EVRI HIV prevention preparedness trial.

Authors:  Anna R Giuliano; Matthys H Botha; Michele Zeier; Martha E Abrahamsen; Richard H Glashoff; Louvina E van der Laan; Mary Papenfuss; Susan Engelbrecht; Maarten F Schim van der Loeff; Staci L Sudenga; Benji N Torres; Siegfried Kipping; Douglas Taylor
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-01       Impact factor: 3.731

4.  Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.

Authors:  Dan Apter; Cosette M Wheeler; Jorma Paavonen; Xavier Castellsagué; Suzanne M Garland; S Rachel Skinner; Paulo Naud; Jorge Salmerón; Song-Nan Chow; Henry C Kitchener; Julio C Teixeira; Unnop Jaisamrarn; Genara Limson; Anne Szarewski; Barbara Romanowski; Fred Y Aoki; Tino F Schwarz; Willy A J Poppe; F Xavier Bosch; Adrian Mindel; Philippe de Sutter; Karin Hardt; Toufik Zahaf; Dominique Descamps; Frank Struyf; Matti Lehtinen; Gary Dubin
Journal:  Clin Vaccine Immunol       Date:  2015-02-04

5.  Prevalence of High Risk HPV in HIV-Infected Women From Belém, Pará, Amazon Region of Brazil: A Cross-Sectional Study.

Authors:  Jacqueline Cortinhas Monteiro; Ricardo Roberto de Souza Fonseca; Tuane Carolina de Sousa Ferreira; Luana Lorena Silva Rodrigues; Andreza Reis Brasil da Silva; Samara Tatielle Gomes; Rodrigo Vellasco Duarte Silvestre; Andréa Nazaré Monteiro Rangel Silva; Ilze Pamplona; Antonio Carlos Rosário Vallinoto; Ricardo Ishak; Luiz Fernando Almeida Machado
Journal:  Front Public Health       Date:  2021-04-29

6.  Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies.

Authors:  Donatella Panatto; Daniela Amicizia; Cecilia Trucchi; Francesca Casabona; Piero Luigi Lai; Paolo Bonanni; Sara Boccalini; Angela Bechini; Emilia Tiscione; Carla Maria Zotti; Rosa Cristina Coppola; Giuseppina Masia; Angelo Meloni; Paolo Castiglia; Andrea Piana; Roberto Gasparini
Journal:  BMC Public Health       Date:  2012-08-07       Impact factor: 3.295

7.  Understanding Public Perceptions of the HPV Vaccination Based on Online Comments to Canadian News Articles.

Authors:  Yael Feinberg; Jennifer A Pereira; Susan Quach; Jeffrey C Kwong; Natasha S Crowcroft; Sarah E Wilson; Maryse Guay; Yang Lei; Shelley L Deeks
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

8.  Detection and genotyping of human papillomavirus in urine samples from unvaccinated male and female adolescents in Italy.

Authors:  Silvia Bianchi; Elena Rosanna Frati; Donatella Panatto; Marianna Martinelli; Daniela Amicizia; Carla Maria Zotti; Morena Martinese; Paolo Bonanni; Sara Boccalini; Rosa Cristina Coppola; Giuseppina Masia; Angelo Meloni; Paolo Castiglia; Andrea Piana; Roberto Gasparini; Elisabetta Tanzi
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

9.  HPV infection and cervical neoplasia: associated risk factors.

Authors:  Andrea Alves Ribeiro; Maria Cecília Costa; Rosane Ribeiro Figueiredo Alves; Luísa Lina Villa; Vera Aparecida Saddi; Megmar Aparecida Dos Santos Carneiro; Luiz Carlos Zeferino; Sílvia Helena Rabelo-Santos
Journal:  Infect Agent Cancer       Date:  2015-05-26       Impact factor: 2.965

10.  Persistence of immune responses to the HPV-16/18 AS04-adjuvanted vaccine in women aged 15-55 years and first-time modelling of antibody responses in mature women: results from an open-label 6-year follow-up study.

Authors:  T Schwarz; M Spaczynski; A Kaufmann; J Wysocki; A Gałaj; K Schulze; P Suryakiran; F Thomas; D Descamps
Journal:  BJOG       Date:  2014-09-11       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.